Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review
Standard
Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review. / Blohm, Martin E G; Göbel, Ulrich.
in: EUR J PEDIATR, Jahrgang 163, Nr. 1, 01.2004, S. 1-6.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review
AU - Blohm, Martin E G
AU - Göbel, Ulrich
PY - 2004/1
Y1 - 2004/1
N2 - UNLABELLED: Infantile choriocarcinoma is a highly malignant germ cell tumour sub-entity thought to originate from the placenta. The aim of this review is to alert clinicians to clinical symptoms and course of neonatal/infantile choriocarcinoma in order to improve the prognosis of affected children by early diagnosis and appropriate treatment. The clinical details of all 30 cases according to a Medline literature search including two cases documented in the MAKEI germ cell tumour study are analysed. Children suffering from infantile choriocarcinoma become symptomatic at a median age of 1 month (range 0 days-5 months). Typical early symptoms with decreasing incidence are anaemia, failure to thrive, hepatomegaly, haemoptysis or respiratory failure, there may be signs of precocious puberty. The tumour affected more than one organ in most cases; organs involved were liver (23/30 cases, 77%), lung (20/30, 67%), brain (8/30, 27%), or skin (3/30, 10%). The natural disease course is rapidly fatal. Without appropriate anti-neoplastic treatment, infantile death occurs on average within 3 weeks from first presentation with a high rate of post-mortem diagnoses (9/28, 32% of live born infants). In recent years, five reported patients (5/30, 18%) achieved a sustained remission after multi-agent cisplatinum-based chemotherapy and delayed (4/5) or primary tumour resection (1/5). beta-Human chorionic gonadotropin was universally elevated in 19/19 tested infants. Maternal choriocarcinoma was reported in 17 of the 30 cases.CONCLUSION: The differential diagnosis of infantile anaemia, failure to thrive and liver enlargement should include infantile choriocarcinoma and prompt measurement of beta-human chorionic gonadotropin.
AB - UNLABELLED: Infantile choriocarcinoma is a highly malignant germ cell tumour sub-entity thought to originate from the placenta. The aim of this review is to alert clinicians to clinical symptoms and course of neonatal/infantile choriocarcinoma in order to improve the prognosis of affected children by early diagnosis and appropriate treatment. The clinical details of all 30 cases according to a Medline literature search including two cases documented in the MAKEI germ cell tumour study are analysed. Children suffering from infantile choriocarcinoma become symptomatic at a median age of 1 month (range 0 days-5 months). Typical early symptoms with decreasing incidence are anaemia, failure to thrive, hepatomegaly, haemoptysis or respiratory failure, there may be signs of precocious puberty. The tumour affected more than one organ in most cases; organs involved were liver (23/30 cases, 77%), lung (20/30, 67%), brain (8/30, 27%), or skin (3/30, 10%). The natural disease course is rapidly fatal. Without appropriate anti-neoplastic treatment, infantile death occurs on average within 3 weeks from first presentation with a high rate of post-mortem diagnoses (9/28, 32% of live born infants). In recent years, five reported patients (5/30, 18%) achieved a sustained remission after multi-agent cisplatinum-based chemotherapy and delayed (4/5) or primary tumour resection (1/5). beta-Human chorionic gonadotropin was universally elevated in 19/19 tested infants. Maternal choriocarcinoma was reported in 17 of the 30 cases.CONCLUSION: The differential diagnosis of infantile anaemia, failure to thrive and liver enlargement should include infantile choriocarcinoma and prompt measurement of beta-human chorionic gonadotropin.
KW - Anemia/etiology
KW - Choriocarcinoma/blood
KW - Chorionic Gonadotropin, beta Subunit, Human/blood
KW - Combined Modality Therapy
KW - Diagnosis, Differential
KW - Failure to Thrive/etiology
KW - Female
KW - Hepatomegaly/etiology
KW - Humans
KW - Infant
KW - Infant, Newborn
KW - Male
KW - Placenta Diseases
KW - Pregnancy
KW - Treatment Outcome
KW - Uterine Neoplasms/blood
U2 - 10.1007/s00431-003-1361-1
DO - 10.1007/s00431-003-1361-1
M3 - SCORING: Review article
C2 - 14628141
VL - 163
SP - 1
EP - 6
JO - EUR J PEDIATR
JF - EUR J PEDIATR
SN - 0340-6199
IS - 1
ER -